📊 ACHC Key Takeaways
Is Acadia Healthcare Company, Inc. (ACHC) a Good Investment?
Acadia Healthcare faces severe operational distress with negative profitability across all metrics, including a -33.3% net margin and -$439.9M free cash flow despite $3.3B in revenue. The company is burning cash operationally while maintaining excessive leverage (1.28x debt-to-equity, $2.5B long-term debt), creating substantial solvency risk. The dramatic revenue increase of 2485.6% YoY suggests a major acquisition or accounting event, yet profitability deteriorated significantly, indicating integration challenges or fundamental business model deterioration.
The fundamentals point to a business with severely impaired profitability, as shown by deeply negative operating and net margins, negative returns on assets and equity, and sharply negative EPS. While liquidity is still adequate and operating cash flow remains positive, the combination of heavy capital spending, negative free cash flow, and substantial debt makes the current growth profile low quality and financially risky.
Why Buy Acadia Healthcare Company, Inc. Stock? ACHC Key Strengths
- Adequate liquidity with 1.55x current ratio and $133.2M cash position providing near-term runway
- Positive operating cash flow of $131.9M suggesting some cash generation despite net losses
- Large revenue base of $3.3B providing market presence in specialty outpatient healthcare
- Revenue scale is large at $3.31B, indicating meaningful market presence
- Current and quick ratios above 1.5x suggest near-term liquidity is not the main issue
- Operating cash flow remains positive at $131.90M despite reported losses
ACHC Stock Risks: Acadia Healthcare Company, Inc. Investment Risks
- Critical profitability crisis: -$1.1B operating loss and -$1.1B net loss with -33.3% net margin indicates fundamental operational failure
- Severely negative free cash flow of -$439.9M combined with $2.5B long-term debt creates imminent refinancing and solvency risk
- Deteriorating shareholder value: -56.6% ROE and -$12.16 diluted EPS demonstrate value destruction and potential equity impairment
- Negative interest coverage of -38.5x indicates inability to service debt from operations, suggesting unsustainable capital structure
- CapEx of $571.8M exceeds operating cash flow, indicating growth investments failing to generate offsetting returns
- Operating margin of -32.2% and net margin of -33.3% indicate severe profitability deterioration
- Free cash flow of -$439.91M shows cash generation is not covering capital needs
- Long-term debt of $2.50B and interest coverage of -38.5x create significant balance-sheet and servicing risk
Key Metrics to Watch
- Operating cash flow trends and sustainability of $131.9M generation amid negative net income
- Debt refinancing schedule and ability to manage $2.5B long-term debt maturity with negative free cash flow
- Path to operating profitability and operating margin recovery from -32.2%
- Quality of revenue growth and contribution margin from the 2485.6% YoY revenue increase
- Capital expenditure efficiency and ROI on $571.8M CapEx investment
- Operating margin and net margin recovery
- Free cash flow trend relative to capital expenditures
Acadia Healthcare Company, Inc. (ACHC) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Acadia Healthcare Company, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
ACHC Profit Margin, ROE & Profitability Analysis
ACHC vs Services Sector: How Acadia Healthcare Company, Inc. Compares
How Acadia Healthcare Company, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Acadia Healthcare Company, Inc. Stock Overvalued? ACHC Valuation Analysis 2026
Based on fundamental analysis, Acadia Healthcare Company, Inc. shows some fundamental concerns relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Acadia Healthcare Company, Inc. Balance Sheet: ACHC Debt, Cash & Liquidity
ACHC Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Acadia Healthcare Company, Inc.'s revenue has grown significantly by 43% over the 5-year period, indicating strong business expansion. The most recent EPS of $-0.24 indicates the company is currently unprofitable.
ACHC Revenue Growth, EPS Growth & YoY Performance
ACHC Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $815.6M | $8.4M | $0.40 |
| Q2 2025 | $796.0M | $8.4M | $0.33 |
| Q1 2025 | $768.1M | $8.4M | $0.09 |
| Q3 2024 | $750.3M | $57.7M | $0.74 |
| Q2 2024 | $731.3M | $57.7M | $0.79 |
| Q1 2024 | $704.3M | $57.7M | $0.72 |
| Q3 2023 | $666.7M | $60.8M | $0.78 |
| Q2 2023 | $651.7M | $60.8M | $0.79 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Acadia Healthcare Company, Inc. Dividends, Buybacks & Capital Allocation
ACHC SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Acadia Healthcare Company, Inc. (CIK: 0001520697)
📋 Recent SEC Filings
❓ Frequently Asked Questions about ACHC
What is the AI rating for ACHC?
Acadia Healthcare Company, Inc. (ACHC) has a Combined AI Rating of STRONG SELL from Claude (STRONG SELL) and ChatGPT (STRONG SELL) with 90% combined confidence, based on fundamental analysis of SEC EDGAR filings.
What are ACHC's key strengths?
Claude: Adequate liquidity with 1.55x current ratio and $133.2M cash position providing near-term runway. Positive operating cash flow of $131.9M suggesting some cash generation despite net losses. ChatGPT: Revenue scale is large at $3.31B, indicating meaningful market presence. Current and quick ratios above 1.5x suggest near-term liquidity is not the main issue.
What are the risks of investing in ACHC?
Claude: Critical profitability crisis: -$1.1B operating loss and -$1.1B net loss with -33.3% net margin indicates fundamental operational failure. Severely negative free cash flow of -$439.9M combined with $2.5B long-term debt creates imminent refinancing and solvency risk. ChatGPT: Operating margin of -32.2% and net margin of -33.3% indicate severe profitability deterioration. Free cash flow of -$439.91M shows cash generation is not covering capital needs.
What is ACHC's revenue and growth?
Acadia Healthcare Company, Inc. reported revenue of $3.3B.
Does ACHC pay dividends?
Acadia Healthcare Company, Inc. does not currently pay dividends.
Where can I find ACHC SEC filings?
Official SEC filings for Acadia Healthcare Company, Inc. (CIK: 0001520697) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is ACHC's EPS?
Acadia Healthcare Company, Inc. has a diluted EPS of $-12.16.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is ACHC a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Acadia Healthcare Company, Inc. has a STRONG SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is ACHC stock overvalued or undervalued?
Valuation metrics for ACHC: ROE of -56.6% (sector avg: 16%), net margin of -33.3% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy ACHC stock in 2026?
Our dual AI analysis gives Acadia Healthcare Company, Inc. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is ACHC's free cash flow?
Acadia Healthcare Company, Inc.'s operating cash flow is $131.9M, with capital expenditures of $571.8M. FCF margin is -13.3%.
How does ACHC compare to other Services stocks?
Vs Services sector averages: Net margin -33.3% (avg: 10%), ROE -56.6% (avg: 16%), current ratio 1.55 (avg: 1.5).